Elevai Labs announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at meeting Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2). The split will automatically consolidate every 200 shares of common stock into one share, with shareholders receiving one full share for fractional portions.The company will maintain its "ELAB" trading symbol but receive a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding. The company will proportionally adjust outstanding stock awards, options, and the equity incentive plan to reflect the new share structure.CEO Graydon Bensler emphasized that this measure is necessary to preserve Elevai's Nasdaq listing and support continued progress. Shareholders holding shares through brokers will see automatic updates, while certificate holders can exchange their certificates through VStock Transfer, LLC.

Elevai Labs announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at meeting Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2). The split will automatically consolidate every 200 shares of common stock into one share, with shareholders receiving one full share for fractional portions.The company will maintain its "ELAB" trading symbol but receive a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding. The company will proportionally adjust outstanding stock awards, options, and the equity incentive plan to reflect the new share structure.CEO Graydon Bensler emphasized that this measure is necessary to preserve Elevai's Nasdaq listing and support continued progress. Shareholders holding shares through brokers will see automatic updates, while certificate holders can exchange their certificates through VStock Transfer, LLC.